Prelude Therapeutics goes public with $158M IPO; stock up nearly 50% in early trading
September 25, 2020 at 12:31 PM EDT
The company is the fifth Philadelphia-area life sciences companies to go public this year through an IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|